you are here: HomeNewsCoronavirus
coronavirus

The new coronavirus strain, first discovered in the central city of Wuhan, has caused alarm because of its connection to Severe Acute Respiratory Syndrome (SARS), which killed nearly 650 people across mainland China and Hong Kong in 2002-2003. More

Jump to
15877 Results Found
  • Tata Group to infuse $50 million in AirAsia India: Report Nov 24, 2020 02:26 PM IST

    Tata Group to infuse $50 million in AirAsia India: Report

    The $50 million funding will be a mix of debt and equity that may push Tata Group’s stake in the business above the present 51 percent

  • Coronavirus Daily Update: COVID-19 cases explained in charts Nov 24, 2020 02:08 PM IST

    Coronavirus Daily Update: COVID-19 cases explained in charts

    India reported less than 40,000 new cases according to official update, on November 24, continuing the streak for the 17th consecutive day of registering less than 50,000 new cases of novel coronavirus.

  • Task force set up in Maharashtra to manage vaccine distribution: CM Uddhav Thackeray Nov 24, 2020 01:35 PM IST

    Task force set up in Maharashtra to manage vaccine distribution: CM Uddhav Thackeray

    According to an official statement, Thackeray made the remarks during Prime Minister Narendra Modi's meeting via video conferencing with chief ministers of eight states which have reported higher number of COVID-19 cases.

  • Experts point out 'gaps' in AstraZeneca’s COVID-19 vaccine data Nov 24, 2020 12:51 PM IST

    Experts point out 'gaps' in AstraZeneca’s COVID-19 vaccine data

    Experts, including those from US' FDA and CDC, have questioned the safety and highlighted the difference in the effectiveness of doses among other 'glaring absences' in the data released by AstraZeneca on November 23.

  • Coronavirus Vaccine | From cost, efficacy, availability to storage, here’s everything you need to know about frontrunners Nov 24, 2020 12:26 PM IST

    Coronavirus Vaccine | From cost, efficacy, availability to storage, here’s everything you need to know about frontrunners

    Pfizer-BioNTech’s vaccine has shown 95 percent efficacy while Moderna’s is 94.5 percent effective but they need some of the coldest temperatures for storage. Oxford-AstraZeneca’s vaccine is 70 percent effective and can be handled at normal refrigerated conditions, hence best suited for India.

  • COVID-19: One crore frontline healthcare workers identified to received vaccine in first phase Nov 24, 2020 11:59 AM IST

    COVID-19: One crore frontline healthcare workers identified to received vaccine in first phase

    Five vaccine candidates are in advanced stages of development in India, out of which four are in Phase II/III and one is in Phase-I/II trials.

  • PM Modi holds virtual meet with states over COVID-19 situation Nov 24, 2020 11:38 AM IST

    PM Modi holds virtual meet with states over COVID-19 situation

    The leaders attending the meeting include Home Minister Amit Shah, Health Minister Harsh Vardhan, Rajasthan Chief Minister Ashok Gehlot, West Bengal Chief Minister Mamata Banerjee, Maharashtra Chief Minister Uddhav Thackeray, Chhattisgarh Chief Minister Bhupesh Baghel and Gujarat Chief Minister Vijay Rupani.

  • Explained: Maharashtra’s new rules for inter-state travel amid COVID-19 resurgence Nov 24, 2020 11:35 AM IST

    Explained: Maharashtra’s new rules for inter-state travel amid COVID-19 resurgence

    Fearing a resurgence in COVID-19 cases, India's worst-affected state Maharashtra has made RT-PCR test mandatory for people entering by air, train or by road from Delhi, Goa, Gujarat and Rajasthan.

  • COVID-19 vaccine | Serum Institute can apply for emergency use if AstraZeneca gets UK nod, says Dr Guleria Nov 24, 2020 11:16 AM IST

    COVID-19 vaccine | Serum Institute can apply for emergency use if AstraZeneca gets UK nod, says Dr Guleria

    If the vaccine is approved by the UK authorities, Serum Institute could also apply for emergency use in India based on the same data, Dr Guleria, a member of the Centre’s task force on vaccines, has said.

  • Coronavirus state-wise tally November 24: Delhi's COVID-19 count rises to 5.3 lakh, death toll at 8,512 Nov 24, 2020 10:45 AM IST

    Coronavirus state-wise tally November 24: Delhi's COVID-19 count rises to 5.3 lakh, death toll at 8,512

    With more than 17.8 lakh COVID-19 cases, Maharashtra has reported the highest number of infections, followed by Karnataka (8.74 lakh) and Andhra Pradesh (8.62 lakh).

  • Coronavirus update: COVID-19 caseload in India climbs to 91.77 lakh, 37,975 new cases reported Nov 24, 2020 10:39 AM IST

    Coronavirus update: COVID-19 caseload in India climbs to 91.77 lakh, 37,975 new cases reported

    The total coronavirus cases mounted to91,77,840 and the death toll climbed to1,34,218 with 480 new fatalities, including 121 from the national capital alone, the data updated at 8 am showed.

  • Oxford-AstraZeneca vaccine: Serum Institute chief says India could approve emergency use by December 2020 Nov 24, 2020 10:10 AM IST

    Oxford-AstraZeneca vaccine: Serum Institute chief says India could approve emergency use by December 2020

    Adar Poonawalla, CEO of the world's largest vaccine makers by volume, expects India to have around 400 million doses of Covishield by July 2021.

  • COVID-19 vaccine | People should be warned about side effects, doctors tell US CDC Nov 24, 2020 09:26 AM IST

    COVID-19 vaccine | People should be warned about side effects, doctors tell US CDC

    Doctors have said that people need to be prepared for the possibility that they may feel a little unwell after taking doses of the vaccine against COVID-19, the disease caused by the novel coronavirus.

  • COVID: Delhi CM Arvind Kejriwal orders immediate procurement of 1,200 BiPAP machines for new ICU beds Nov 24, 2020 09:24 AM IST

    COVID: Delhi CM Arvind Kejriwal orders immediate procurement of 1,200 BiPAP machines for new ICU beds

    A total of 1,200 BiPAP machines will be procured immediately from the Council of Scientific and Industrial Research (CSIR), the official said.

  • PM Modi must tell nation which COVID vaccine will India select: Rahul Gandhi Nov 24, 2020 08:20 AM IST

    PM Modi must tell nation which COVID vaccine will India select: Rahul Gandhi

    As the race for the COVID vaccine hots up with many players claiming successful trials, Gandhi posed several questions to the prime minister on the country''s vaccine distribution strategy.

  • PM Modi likely to discuss COVID-19 vaccination strategy, resurgence in cases with CMs today Nov 24, 2020 08:11 AM IST

    PM Modi likely to discuss COVID-19 vaccination strategy, resurgence in cases with CMs today

    PM Narendra Modi is likely to discuss with states the cause for the recent resurgence in daily COVID-19 cases and finalise a mechanism for vaccine distribution.

  • Coronavirus News highlights | Delhi reports 6,224 fresh COVID-19 cases, 109 deaths Nov 24, 2020 07:20 AM IST

    Coronavirus News highlights | Delhi reports 6,224 fresh COVID-19 cases, 109 deaths

    Coronavirus News highlights: Total COVID-19 cases in India have risen to 91 lakh. There are 4,38,667 active cases in the country.

  • COVID blues | For movie business, the struggle will continue even next year Nov 23, 2020 07:10 PM IST

    COVID blues | For movie business, the struggle will continue even next year

    Fewer releases are expected for the first half of 2021.

  • Why AstraZeneca-Oxford COVID vaccine is best suited for India over Pfizer, Moderna shots Nov 23, 2020 06:54 PM IST

    Why AstraZeneca-Oxford COVID vaccine is best suited for India over Pfizer, Moderna shots

    With pricing and ease of storage being key determinants, Covidshield may well be the answer to India's coronavirus woes. If all goes well, the Serum Institute of India could be providing AstraZeneca-Oxford's vaccine to Indians early next year.

  • S&P says credit risks for India infrastructure sector rising Nov 23, 2020 06:35 PM IST

    S&P says credit risks for India infrastructure sector rising

    Increasing debt, weakening counterparties and difficulty in refinancing could keep the infrastructure sector under pressure, according to the rating agency

  • Big Story | How Pfizer, Moderna, AstraZeneca COVID-19 vaccines are placed in terms of availability? Nov 23, 2020 06:13 PM IST

    Big Story | How Pfizer, Moderna, AstraZeneca COVID-19 vaccines are placed in terms of availability?

    The last two weeks have seen a string of encouraging results from COVID-19 vaccine trials with several experimental vaccines having proved over 90% effectiveness at preventing disease in late-stage clinical trials. Let's find out if the hunt for the vaccine over

  • After malaria and COVID-19, British man survives cobra bite in India Nov 23, 2020 05:31 PM IST

    After malaria and COVID-19, British man survives cobra bite in India

    Ian Jones was bitten by an Indian cobra in rural Jodhpur district of the desert state and admitted to hospital in Jodhpur city, about 350 kilometres (220 miles) from the regional capital Jaipur.

  • COVID-19 cases in US may double before Joe Biden takes office: Study Nov 23, 2020 05:25 PM IST

    COVID-19 cases in US may double before Joe Biden takes office: Study

    The research, published in the journal Scientific reports, applied a mathematical model which had accurately forecasted the rate of COVID-19 growth over the summer of 2020.

  • Business Insight | Moderna to charge $25-$37 per dose for its COVID-19 vaccine Nov 23, 2020 05:03 PM IST

    Business Insight | Moderna to charge $25-$37 per dose for its COVID-19 vaccine

    Moderna’s CEO has said the company will charge governments $25 and $37 per dose for its COVID-19 vaccine

  • AstraZeneca will have 200 million COVID-19 vaccine doses by year-end Nov 23, 2020 04:41 PM IST

    AstraZeneca will have 200 million COVID-19 vaccine doses by year-end

    Pam Cheng said there would be enough vaccine for 20 million doses in Britain by the end of the year, with enough "active" drug substance for 70 million doses for the UK by the end of Q1 2021.

Sections